Maintain pressure on reforms to protect NHSBPH drug approved for use
The Scottish Medicines Consortium has approved Combodart (dutasteride 0.5mg/tamsulosin hydrochloride 0.4mg) for the treatment of benign prostatic hyperplasia (BPH) within NHS Scotland.
The drug is indicated for the treatment of moderate-to-severe BPH and reduction in the risk of acute urinary retention and BPH-related surgery.
Introducing Nursing Times Learning
Subscribers get five FREE learning units and non-subscribers can access each learning unit for £10 + VAT.
Click on the topics below to get started:
Online training units, written and reviewed by experts. Earn two hours' CPD and a personalised certificate for your portfolio.
Subscribers get five FREE learning units and non-subscribers can access each learning unit for £10 + VAT.
Share
Have your say
You must sign in to make a comment.